Spectrum of Factors Triggering Endothelial Dysfunction in PIH

Introduction: Pre-eclampsia (PE) is a major cause of maternal and fetal/neonatal mortality and morbidity. The aetiology and pathogenesis of PE is yet to be completely understood. Evidence shows that, Endothelial Dysfunction (ED) plays a pivotal role in the genesis of this multi-system disorder t...

Full description

Bibliographic Details
Main Authors: Visala Sree Jammalamadaga, Philips Abraham
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2016-12-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/9023/22113_CE(RA1)_F(T)_PF1(PI_RK)_PFA(NC_AK)_PF2(PAG).pdf
id doaj-4f019a0ff58c4658bc0e599dd5d28c76
record_format Article
spelling doaj-4f019a0ff58c4658bc0e599dd5d28c762020-11-25T03:23:13ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2016-12-011012BC14BC1710.7860/JCDR/2016/22113.9023Spectrum of Factors Triggering Endothelial Dysfunction in PIHVisala Sree Jammalamadaga0Philips Abraham1Research Scholar, Department of Biochemistry, Annapoorana Medical College and Hospital, Salem, Tamil Nadu, India.Associate Professor, Department of Biochemistry, Vinayaka Missions Kirupananda Variyar Medical College and Hospital, Salem, Tamil Nadu, India.Introduction: Pre-eclampsia (PE) is a major cause of maternal and fetal/neonatal mortality and morbidity. The aetiology and pathogenesis of PE is yet to be completely understood. Evidence shows that, Endothelial Dysfunction (ED) plays a pivotal role in the genesis of this multi-system disorder that develops in PE and eclampsia. Aim: To determine the circulating levels of factors Malondialdehyde (MDA), Ferric Reducing Ability of Plasma-α (FRAP), Tumour Necrosis Factor (TNF-α), sFlt-1, VEGF, PlGF, Nitric Oxide (NO) that influence the ED. Materials and Methods: Study groups consisted of Normotensive pregnant women (N), preeclamptic women (PE) and eclamptic women (E) with 100 subjects in each group in the 3rd trimester of pregnancy. They were investigated for MDA, FRAP, TNF-α, sFlt-1, VEGF, PlGF, NO. Statistical analysis was done using Analysis of Variance (ANOVA). Results: When compared to controls MDA, TNF-α, sFlt-1 levels were found to be significantly high and FRAP, VEGF, PIGF and NO levels were significantly low in PE and E group. E showed a significantly high level of MDA, TNF-α, sFlt-1 and low levels of FRAP, VEGF, PIGF, NO when compared to PE group. Conclusion: Our study substantiated the fact, that oxidative stress, imbalance between anti-angiogenic factors and proangiogenic factors exists in Pregnancy Induced Hypertension (PIH) condition. This imbalance is directly related to the ED, the hallmark of PE. So oxidative stress, VEGF, PlGF and sFlt-1 can be used as markers to analyze the onset and progression of the disease.https://jcdr.net/articles/PDF/9023/22113_CE(RA1)_F(T)_PF1(PI_RK)_PFA(NC_AK)_PF2(PAG).pdfendothelial dysfuctionferric reducing ability of plasmamalondialdehydenitric oxideplacental growth factorpregnancy induced hypertensionsoluble fms-like tyrosine kinasetumour necrosis factorvascular endothelial growth factor
collection DOAJ
language English
format Article
sources DOAJ
author Visala Sree Jammalamadaga
Philips Abraham
spellingShingle Visala Sree Jammalamadaga
Philips Abraham
Spectrum of Factors Triggering Endothelial Dysfunction in PIH
Journal of Clinical and Diagnostic Research
endothelial dysfuction
ferric reducing ability of plasma
malondialdehyde
nitric oxide
placental growth factor
pregnancy induced hypertension
soluble fms-like tyrosine kinase
tumour necrosis factor
vascular endothelial growth factor
author_facet Visala Sree Jammalamadaga
Philips Abraham
author_sort Visala Sree Jammalamadaga
title Spectrum of Factors Triggering Endothelial Dysfunction in PIH
title_short Spectrum of Factors Triggering Endothelial Dysfunction in PIH
title_full Spectrum of Factors Triggering Endothelial Dysfunction in PIH
title_fullStr Spectrum of Factors Triggering Endothelial Dysfunction in PIH
title_full_unstemmed Spectrum of Factors Triggering Endothelial Dysfunction in PIH
title_sort spectrum of factors triggering endothelial dysfunction in pih
publisher JCDR Research and Publications Private Limited
series Journal of Clinical and Diagnostic Research
issn 2249-782X
0973-709X
publishDate 2016-12-01
description Introduction: Pre-eclampsia (PE) is a major cause of maternal and fetal/neonatal mortality and morbidity. The aetiology and pathogenesis of PE is yet to be completely understood. Evidence shows that, Endothelial Dysfunction (ED) plays a pivotal role in the genesis of this multi-system disorder that develops in PE and eclampsia. Aim: To determine the circulating levels of factors Malondialdehyde (MDA), Ferric Reducing Ability of Plasma-α (FRAP), Tumour Necrosis Factor (TNF-α), sFlt-1, VEGF, PlGF, Nitric Oxide (NO) that influence the ED. Materials and Methods: Study groups consisted of Normotensive pregnant women (N), preeclamptic women (PE) and eclamptic women (E) with 100 subjects in each group in the 3rd trimester of pregnancy. They were investigated for MDA, FRAP, TNF-α, sFlt-1, VEGF, PlGF, NO. Statistical analysis was done using Analysis of Variance (ANOVA). Results: When compared to controls MDA, TNF-α, sFlt-1 levels were found to be significantly high and FRAP, VEGF, PIGF and NO levels were significantly low in PE and E group. E showed a significantly high level of MDA, TNF-α, sFlt-1 and low levels of FRAP, VEGF, PIGF, NO when compared to PE group. Conclusion: Our study substantiated the fact, that oxidative stress, imbalance between anti-angiogenic factors and proangiogenic factors exists in Pregnancy Induced Hypertension (PIH) condition. This imbalance is directly related to the ED, the hallmark of PE. So oxidative stress, VEGF, PlGF and sFlt-1 can be used as markers to analyze the onset and progression of the disease.
topic endothelial dysfuction
ferric reducing ability of plasma
malondialdehyde
nitric oxide
placental growth factor
pregnancy induced hypertension
soluble fms-like tyrosine kinase
tumour necrosis factor
vascular endothelial growth factor
url https://jcdr.net/articles/PDF/9023/22113_CE(RA1)_F(T)_PF1(PI_RK)_PFA(NC_AK)_PF2(PAG).pdf
work_keys_str_mv AT visalasreejammalamadaga spectrumoffactorstriggeringendothelialdysfunctioninpih
AT philipsabraham spectrumoffactorstriggeringendothelialdysfunctioninpih
_version_ 1724606835915227136